Highbridge Capital Management’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,624
Closed -$238K 1846
2017
Q3
$238K Buy
+5,624
New +$227K ﹤0.01% 1331
2017
Q2
Sell
-8,924
Closed -$257K 1470
2017
Q1
$257K Sell
8,924
-35,279
-80% -$988K ﹤0.01% 1220
2016
Q4
$1.17M Buy
44,203
+27,681
+168% +$668K 0.02% 504
2016
Q3
$401K Sell
16,522
-28,741
-63% -$664K 0.01% 883
2016
Q2
$897K Buy
45,263
+19,439
+75% +$374K 0.01% 647
2016
Q1
$477K Sell
25,824
-30,510
-54% -$529K 0.01% 998
2015
Q4
$1.05M Sell
56,334
-20,000
-26% -$402K 0.02% 733
2015
Q3
$1.82M Buy
76,334
+64,605
+551% +$1.52M 0.03% 571
2015
Q2
$253K Sell
11,729
-14,385
-55% -$292K ﹤0.01% 1200
2015
Q1
$503K Buy
+26,114
New +$465K 0.01% 966
2014
Q2
Sell
-24,348
Closed -$348K 1204
2014
Q1
$348K Sell
24,348
-2,797
-10% -$41.5K ﹤0.01% 802
2013
Q4
$428K Buy
27,145
+12,066
+80% +$183K 0.01% 715
2013
Q3
$183K Buy
+15,079
New +$194K ﹤0.01% 1180

Other funds holding MMSI

Highbridge Capital Management's MMSI Position: Q4 2017 in Review

Highbridge Capital Management sold out of Merit Medical Systems (MMSI) in Q4 2017, closing a stake of 5,624 shares — an estimated $238K sold.

Highbridge Capital Management first reported a position in MMSI in Q3 2013 and held it in 13 quarters. The position peaked at $1.82M in Q3 2015. 214 funds tracked by Wall St. Rank hold MMSI as of Q4 2017.

  • Highbridge Capital Management reported no remaining Merit Medical Systems position as of Q4 2017 after selling out during the quarter.
  • Highbridge Capital Management sold 5,624 Merit Medical Systems shares in Q4 2017, an estimated $238K.
  • Highbridge Capital Management first reported a position in Merit Medical Systems in Q3 2013 and held it in 13 quarters.
  • Highbridge Capital Management's Merit Medical Systems position peaked at $1.82M in Q3 2015.
  • 214 funds tracked by Wall St. Rank held Merit Medical Systems as of Q4 2017.

Based on Highbridge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.